MIT Holding, Inc. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2016-02-11: Form 8-K; Period of report 2016-02-01; Description 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review; Details 4.02.
- 2015-10-22: Form 8-K; Period of report 2015-10-05; Description 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review; Details 4.02.
- 2012-03-06: Form 8-K; Period of report 2012-03-05; Description 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review; Details 4.02.
- 2012-02-16: Form 8-K; Period of report 2012-02-14; Description 2.01 Completion of Acquisition or Disposition of Assets; Details 2.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2016-02-11 | 8-K | 2016-02-01 | 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review | 4.02 On December 31, 2015, the Board of Directors of MIT Holding, Inc. (the “Company”) determined that the Company’s previously issued unaudited and unreviewed consolidated financial statements contained in our September 30, 2015 Form 10-Q filed on November 25, 2015 should no longer be relied upon. | form8-k.htm |
| 2015-10-22 | 8-K | 2015-10-05 | 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review | 4.02 On October 5, 2015, the Board of Directors of MIT Holding, Inc. (the “Company”) determined that the Company’s previously issued unaudited and unreviewed consolidated financial statements for the periods from March 31, 2011 to June 30, 2015 should no longer be relied upon. | form8-k.htm |
| 2012-03-06 | 8-K | 2012-03-05 | 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review | 4.02 On February 27, 2012, the board of directors of MIT Holding, Inc. (the “Company”) determined that the Company’s previously issued interim consolidated financial statements for the three months ended March 31, 2011 and the three and six months ended June 30, 2011 and for the three and nine months ended September 30, 2011 should no longer be relied upon due to the inability to complete an independent financial audit of the acquired companies; Palmetto Long Term Care Pharmacy, Inc. and National Direct Home Pharmacy, Inc. The Purchases closed on February 4, 2011 and the sale of Palmetto Long Term Pharmacy, Inc and National Direct Home Pharmacy, Inc. occurred September 20, 2011. | form8k.htm |
| 2012-02-16 | 8-K | 2012-02-14 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 On December 31, 2010, MIT Holding Inc. (“MIT” or the “Company”) executed Stock Purchase agreements, through it’s South Carolina Subsidiary, MITRX Corporation, acquiring One hundred Percent (100%) of the companies; National Direct Home Pharmacy, Inc owned by Lancelot D. Wright and John T. Crocker, Sr. and Palmetto Long Term Pharmacy, LLC a wholly owned subsidiary of Strategies Healthcare, LLC which is owned by Lancelot D. Wright and Robert A. Williams. | form8k.htm |
| 2011-09-23 | 8-K | 2011-09-22 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 On September 20, 2011, MITRX Corporation, a wholly owned subsidiary of MIT Holding Inc. (“MIT” or the “Company”) executed two Stock Purchase agreements selling One hundred Percent (100%) of each of the companies; National Direct Home Pharmacy, Inc to TDT Investments Inc. and Palmetto Long Term Care Pharmacy, Inc. to Pharmco, Inc. There are no material relationships between the purchasers, its owners, affiliates, officers or directors and MIT’s officers, directors or affiliates, other than Tommy Duncan is a long term director of MIT, who abstained from any voting pertaining to these transactions. | mit_8k.htm |
| 2011-05-24 | 8-K | 2011-05-24 | 1.01 Entry into a Material Definitive Agreement | 1.01 On May 11, 2011, MIT Holding Inc. (“MIT” or the “Company”), executed a five year agreement (attached hereto as Exhibit 10.18) with Global Reach International, Inc., for the appointment as distributor of Seven Million Two Hundred Thousand (7,200,000) units of the Provector, with an aggregate value of Eighty-Six Million Five Hundred Thousand ($86,500,000.00) Dollars over a period of five years with a projected profit of Thirty-Six Million ($36,000,000.00) Dollars. | v224054_8k.htm |
| 2011-04-14 | 8-K | 2011-04-14 | 1.02 Termination of a Material Definitive Agreement | 1.02 On April 11, 2011, MIT Holding Inc. (“MIT” or the “Company”) through its subsidiary, MITRX Corporation, terminated the Letter of Intent to acquire one hundred Percent (100%) of Fitte Enterprises, Inc dba CRD MedServices, LLC, a retail/mail order pharmacy with locations in Texas, South Caroline and Florida (The agreement was attached as Exhibit 10.18 to the Company Form 8-K, filed on March 31, 2011). | mitholding8k041411.htm |
| 2011-03-31 | 8-K | 2011-03-18 | 1.01 Entry into a Material Definitive Agreement | 1.01 Effective March 18, 2011, MIT Holding Inc. (“MIT” or the “Company”) through its subsidiary, MITRX Corporation, executed a Letter of Intent (attached hereto as Exhibit 10.18) to acquire one hundred Percent (100%) of Fitte Enterprises, Inc dba CRD MedServices, LLC, a retail/mail order pharmacy with locations in Texas, South Caroline and Florida. | mit8kfitte033111.htm |
| 2011-02-09 | 8-K | 2011-02-04 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 On February 4, 2011, MITRX Corporation, a South Carolina corporation and subsidiary of MIT Holding Inc. (“MIT” or the “Company”), executed two stock purchase agreements (attached hereto as Exhibit 10.19 and 10.20) (the “Agreements”), pursuant to which it agreed to acquire one hundred Percent (100%) of the issued and outstanding equity interests of two companies; National Direct Home Pharmacy, Inc., owned by Lancelot D. Wright and John T. Crocker, Sr., and Palmetto Long Term Care Pharmacy, LLC a wholly owned subsidiary of Strategies Healthcare, Inc., which is owned by Lancelot D. Wright and Robert A. Williams. | mit8k020911final.htm |
| 2011-01-06 | 8-K | 2010-12-22 | 1.01 Entry into a Material Definitive Agreement | 1.01 On December 22, 2010, MIT Holding Inc. (“MIT” or the “Company”) executed a Letter of Intent (attached hereto as Exhibit 10.18) to acquire one hundred Percent (100%) of the two companies, National Direct Home Pharmacy, Inc and Palmetto Long Term Pharmacy, LLC in South Carolina. | mit_holding8k1229101.htm |
| 2010-10-22 | 8-K | 2010-10-20 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On October 20, 2010, MIT Holding Inc. (“MIT” or the “Company”) announced that on August 16, 2010 its Board of Directors had accepted the resignation of John Sabia (“Sabia”) from his positions as Chief Financial Officer, Secretary and Board Member for MIT. | mitholding8k102210.htm |
| 2010-10-20 | 8-K | 2010-10-13 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 MIT Holding Inc. and Vivakor Inc. executed an exclusive license agreement as of October 13, 2010. 8.01 On October 13, 2010, MIT Holding Inc. issued a press release announcing the agreement with Vivakor. | v199546_8-k.htm |
| 2009-08-12 | 8-K/A | 2009-06-24 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On June 24, 2009, the Company’s independent accountants, Drakeford and Drakeford LLC (“Drakeford”) advised the Company that it must refuse to stand for re-election as the Company’s independent certified public accountant. | v157461_8ka.htm |
| 2009-08-06 | 8-K | 2009-06-24 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On June 24, 2009, the Company’s former independent accountants, Drakeford and Drakeford LLC (“Drakeford”) advised the company that it must refuse to stand for re-election as the Company’s independent certified public accountant and resigned. | v156709_8k.htm |
| 2007-10-10 | 8-K | 2007-10-02 | 8.01 Other Events | v089912_8k.htm | |
| 2007-07-27 | 8-K/A | 2007-05-04 | 4.01 Changes in Registrant's Certifying Accountant | v082105_8-ka.htm | |
| 2007-06-26 | 8-K | 2007-05-04 | 4.01 Changes in Registrant's Certifying Accountant; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | v079309_8k.htm | |
| 2007-05-08 | 8-K | 2007-05-02 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.06 Change in Shell Company Status | v074042_8k.htm | |
| 2007-04-11 | 8-K | 2007-04-05 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | y33157e8vk.htm |